檢索結果 - Katherine I. Lin

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

    The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course 由 Constantine S. Tam, Lynne V. Abruzzo, Katherine I. Lin, Jorge E. Cortés, Alice Lynn, Michael J. Keating, Deborah A. Thomas, Sherry Pierce, Hagop M. Kantarjian, Srđan Verstovšek

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells

    Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells 由 Shilpee Dutt, Anupama Narla, Katherine I. Lin, Ann Mullally, Nirmalee Abayasekara, Christine Megerdichian, Frederick H. Wilson, Treeve Currie, Arati Khanna‐Gupta, Nancy Berliner, Jeffery L. Kutok, Benjamin L. Ebert

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Acoustic separation and concentration of exosomes for nucleotide detection: ASCENDx

    Acoustic separation and concentration of exosomes for nucleotide detection: ASCENDx 由 Ty Naquin, Aidan J. Canning, Yuyang Gu, Jianing Chen, Chloe M. Naquin, Jianping Xia, Brandon Lu, Shujie Yang, Aleksandra Koroza, Katherine I. Lin, Hsin‐Neng Wang, William R. Jeck, Luke P. Lee, Tuan Vo‐Dinh, Tony Jun Huang

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens

    Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related... 由 Katherine I. Lin, Constantine S. Tam, Michael J. Keating, William G. Wierda, Susan O’Brien, Susan Lerner, Kevin R. Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L. Barron, Thomas J. Kipps, Laura Z. Rassenti, Stefan Faderl, Hagop M. Kantarjian, Lynne V. Abruzzo

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease

    Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease 由 James E. Bradner, Raymond H. Mak, Shyam K. Tanguturi, Ralph Mazitschek, Stephen J. Haggarty, Kenneth N. Ross, Cindy Chang, Jocelyn Bosco, Nathan West, Elizabeth M. Morse, Katherine I. Lin, John Paul Shen, Nicholas Kwiatkowski, Nele Gheldof, Job Dekker, Daniel J. DeAngelo, Steven A. Carr, Stuart L. Schreiber, Todd R. Golub, Benjamin L. Ebert

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: